Global Blood Therapeutics Inc (NASDAQ:GBT)

35.43
Delayed Data
As of May 13
 -1.14 / -3.11%
Today’s Change
34.65
Today|||52-Week Range
76.47
-18.19%
Year-to-Date

Today’s Trading

Previous close36.60
Today’s open36.74
Day’s range34.65 - 36.96
Volume1,192,629
Average volume (3 months)963,140
Market cap$2.4B
Data as of 3:59pm ET, 05/13/2021

Growth & Valuation

Earnings growth (last year)+11.76%
Earnings growth (this year)-11.58%
Earnings growth (next 5 years)0.00%
Revenue growth (last year)+5,773.01%
P/E ratioNM
Price/Sales21.46
Price/Book5.79

Competitors

 Today’s
change
Today’s
% change
PBHPrestige Consumer He...-0.02-0.04%
CORTCorcept Therapeutics...+0.31+1.50%
VCELVericel Corp+0.66+1.40%
OPKOPKO Health Inc+0.08+2.40%
Data as of 4:00pm ET, 05/13/2021

Financials

Next reporting dateAugust 11, 2021
EPS forecast (this quarter)-$1.16
Annual revenue (last year)$123.8M
Annual profit (last year)-$247.6M
Net profit margin-199.96%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
South San Francisco, California

Forecasts